These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23847468)

  • 1. Dopamine, cognitive function, and gamma oscillations: role of D4 receptors.
    Furth KE; Mastwal S; Wang KH; Buonanno A; Vullhorst D
    Front Cell Neurosci; 2013; 7():102. PubMed ID: 23847468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors.
    Andersson RH; Johnston A; Herman PA; Winzer-Serhan UH; Karavanova I; Vullhorst D; Fisahn A; Buonanno A
    Proc Natl Acad Sci U S A; 2012 Aug; 109(32):13118-23. PubMed ID: 22822214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D4 receptor activation increases hippocampal gamma oscillations by enhancing synchronization of fast-spiking interneurons.
    Andersson R; Johnston A; Fisahn A
    PLoS One; 2012; 7(7):e40906. PubMed ID: 22815864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effect of Dopamine D4 Receptor Activation on Low-Frequency Oscillations in the Prefrontal Cortex and Hippocampus May Bias the Bidirectional Prefrontal-Hippocampal Coupling.
    Thörn CW; Kafetzopoulos V; Kocsis B
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia.
    Kocsis B; Lee P; Deth R
    Brain Struct Funct; 2014 Nov; 219(6):2173-80. PubMed ID: 23839116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D4 Receptor Agonist Drastically Increases Delta Activity in the Thalamic Nucleus Reuniens: Potential Role in Communication between Prefrontal Cortex and Hippocampus.
    Kuang J; Kafetzopoulos V; Deth R; Kocsis B
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex.
    Yuen EY; Yan Z
    J Neurosci; 2009 Jan; 29(2):550-62. PubMed ID: 19144855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses.
    Hou XJ; Ni KM; Yang JM; Li XM
    Neuroscience; 2014 Mar; 261():107-17. PubMed ID: 24374327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors.
    Skirzewski M; Karavanova I; Shamir A; Erben L; Garcia-Olivares J; Shin JH; Vullhorst D; Alvarez VA; Amara SG; Buonanno A
    Mol Psychiatry; 2018 Nov; 23(11):2227-2237. PubMed ID: 28727685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation.
    Kawata M; Morikawa S; Shiosaka S; Tamura H
    Transl Psychiatry; 2017 Mar; 7(3):e1052. PubMed ID: 28267150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome.
    Zorrilla de San Martin J; Donato C; Peixoto J; Aguirre A; Choudhary V; De Stasi AM; Lourenço J; Potier MC; Bacci A
    Elife; 2020 Aug; 9():. PubMed ID: 32783810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.
    Uliana DL; Lisboa JRF; Gomes FV; Grace AA
    Biochem Pharmacol; 2024 Oct; 228():116298. PubMed ID: 38782077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets.
    Nakazawa S; Murai T; Miyauchi M; Kotani M; Ikeda K
    Psychopharmacology (Berl); 2015 Sep; 232(17):3287-95. PubMed ID: 26041337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia.
    Fisahn A; Neddens J; Yan L; Buonanno A
    Cereb Cortex; 2009 Mar; 19(3):612-8. PubMed ID: 18632742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders.
    Shi L; Bergson CM
    Transl Psychiatry; 2020 Jun; 10(1):190. PubMed ID: 32546684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation.
    Chen YJ; Zhang M; Yin DM; Wen L; Ting A; Wang P; Lu YS; Zhu XH; Li SJ; Wu CY; Wang XM; Lai C; Xiong WC; Mei L; Gao TM
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21818-23. PubMed ID: 21106764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvalbumin and Somatostatin Interneurons Contribute to the Generation of Hippocampal Gamma Oscillations.
    Antonoudiou P; Tan YL; Kontou G; Upton AL; Mann EO
    J Neurosci; 2020 Sep; 40(40):7668-7687. PubMed ID: 32859716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.
    Gonzalez-Burgos G; Cho RY; Lewis DA
    Biol Psychiatry; 2015 Jun; 77(12):1031-40. PubMed ID: 25863358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior.
    Carlén M; Meletis K; Siegle JH; Cardin JA; Futai K; Vierling-Claassen D; Rühlmann C; Jones SR; Deisseroth K; Sheng M; Moore CI; Tsai LH
    Mol Psychiatry; 2012 May; 17(5):537-48. PubMed ID: 21468034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.